Biotechnology company Biogen Idec outlined plans for a new 180,000 square foot building in Research Triangle Park in a regulatory filing earlier this month.
The company said it plans to consolidate all of its North Carolina administrative and patient services under one roof in a building to be constructed on its RTP campus.
The company could occupy the new building as early as the middle of next year, it wrote in its filing.
Biogen declined to comment beyond what it said in its regulatory filing.
Biogen owns roughly 550,000 square feet of office, warehouse, manufacturing and lab space in RTP. It also leases 50,000 square feet of office space in Durham.
The Massachusetts-based company announced in November that it would revamp its research efforts and eliminate 13 percent of its work force.
The cuts included closing its San Diego site and shutting two of its four sites in Massachusetts. The company is maintaining operations in Weston and Cambridge, Mass., as well as in RTP.
The company's RTP workforce has largely been spared, with just six of the 850 jobs located in the park being cut.
Biogen first opened an RTP facility in 1996 and now has a manufacturing plant and a patient services operation.
Biogen is focusing its R&D efforts on neurological disorders such as Lou Gehrig's disease, Parkinson's disease and multiple sclerosis - an area where it is already a market leader with its Avonex and Tysabri medications.